7 reports

  • STADA ARZNEIMITTEL AG
  • LEADING COMPANIES

One of the largest pharmaceutical companies, Merck, lost patents for four major products in 2017.

  • Pharmaceutical
  • Arzneimittel AG
  • Mylan Inc.
  • Novartis AG
  • STADA Arzneimittel AG

The company is one the world' s largest active pharmaceutical ingredients (APIs) producers.

  • Pharmaceutical
  • Germany
  • World
  • Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd.
  • STADA ARZNEIMITTEL AG

MARKET DATA MARKET VALUE TABLE ##: GERMANY GENERICS MARKET VALUE: $ BILLION, 2011-##(E) FIGURE ##: GERMANY GENERICS MARKET VALUE: $ BILLION, 2011-##(E) The German generics market grew by ##. ##% in 2015 to reach a volume of ##. ## % of total pharma volume.

  • Pharmaceutical
  • Arzneimittel AG
  • Mylan Inc.
  • Sandoz Inc.
  • STADA Arzneimittel AG
  • Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deal Details
  • Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deal Details

Summary Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products.The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of products in various therapeutic...

  • Pharmaceutical
  • Company Sales
  • Demand
  • M&A
  • Arzneimittel AG
  • R&D Overview

In the first six months of 2017, sales increased by ## percent to Euro ##. ## million (##-##/ 2016: Euro ##. ## million).

  • Pharmaceutical
  • Germany
  • Russia
  • Company Financials
  • Arzneimittel AG
  • STADA ARZNEIMITTEL AG: KEY EMPLOYEE BIOGRAPHIES
  • STADA ARZNEIMITTEL AG: COMPANY HISTORY

He was the Head of Pharma, Europe at Novartis Pharma from 2007 to 2012.

  • Pharmaceutical
  • Germany
  • Company
  • Arzneimittel AG
  • DIVESTMENTS - DEAL REPORTS
  • PARTNERSHIP - DEAL REPORTS

Private Partner ##: Eisai China, Inc.

  • Pharmaceutical
  • M&A
  • Arzneimittel AG